Combination Invention

Combination Invention. Any Invention, the practice of which necessarily requires both (1) the presence or direct use of the Sponsor Product, or a TLR9 Agonist or the practice of any Sponsor Intellectual Property, on the one hand, and (2) the presence or direct use of the Regeneron Product or a PD-1 Antagonist or practice of any Regeneron Intellectual Property, on the other hand, in each case (1) and (2) when such Invention is Controlled by Sponsor, by Regeneron, or by both Sponsor and Regeneron.